NCT00001304View on ClinicalTrials.gov

Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 1991

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Hypoparathyroidism
Interventions
DRUG

Synthetic Human Parathyroid Hormone 1-34

twice daily subcutaneous injections

DRUG

Calcitriol & Calcium

Twice daily oral calcitriol with 1000 mg Calcium carbonate supplementation

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00001304 - Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 | Biotech Hunter | Biotech Hunter